Literature DB >> 23635348

Ovarian stimulation in cancer patients.

Hakan Cakmak1, Mitchell P Rosen.   

Abstract

The patients referred for fertility preservation owing to a malignant disease do not represent the typical population of subfertile patients treated in IVF units. Cancer may affect multiple tissues throughout the body and can result in a variety of complications during controlled ovarian stimulation. Determination of the controlled ovarian stimulation protocol and gonadotropin dose for oocyte/embryo cryopreservation requires an individualized assessment. This review highlights the new protocols that are emerging to reduce time constraints and emphasizes management considerations to decrease complications.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23635348     DOI： 10.1016/j.fertnstert.2013.03.029

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  27 in total

1.  Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model?

Authors:  Michelle Soares; Pascale Saussoy; Karima Sahrari; Christiani A Amorim; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  J Assist Reprod Genet       Date:  2015-02-04       Impact factor: 3.412

2.  Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment.

Authors:  M M Dolmans; S Hollanders de Ouderaen; D Demylle; C Pirard
Journal:  J Assist Reprod Genet       Date:  2015-07-15       Impact factor: 3.412

3.  Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?

Authors:  Avner Hershlag; Christine Mullin; Sara L Bristow
Journal:  J Glob Oncol       Date:  2018-09

Review 4.  Ovarian stimulation in the luteal phase: systematic review and meta-analysis.

Authors:  C E Boots; M Meister; A R Cooper; A Hardi; E S Jungheim
Journal:  J Assist Reprod Genet       Date:  2016-05-04       Impact factor: 3.412

5.  The Effects of Negative Elements in Environment and Cancer on Female Reproductive System.

Authors:  Jiangxue Qu; Yuehan Li; Shujie Liao; Jie Yan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model.

Authors:  Jennifer Flora Knudtson; Marlen Tellez Santos; Courtney M Failor; Peter A Binkley; Jacob P Venesky; Rajeshwar R Tekmal; Randal D Robinson; Robert S Schenken
Journal:  Reprod Sci       Date:  2016-12-14       Impact factor: 3.060

7.  Fertility preservation in reproductive-age women facing gonadotoxic treatments.

Authors:  J Roberts; R Ronn; N Tallon; H Holzer
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

8.  Ovarian response to controlled ovarian hyperstimulation in women with cancer is as expected according to an age-specific nomogram.

Authors:  Marta Devesa; Francisca Martínez; Buenaventura Coroleu; Ignacio Rodríguez; Clara González; Pedro Nolasco Barri
Journal:  J Assist Reprod Genet       Date:  2014-02-04       Impact factor: 3.412

9.  Long-term outcomes in cancer patients who did or did not pursue fertility preservation.

Authors:  Molly B Moravek; Rafael Confino; Kristin N Smith; Ralph R Kazer; Susan C Klock; Angela K Lawson; William J Gradishar; Mary Ellen Pavone
Journal:  Fertil Steril       Date:  2018-01-17       Impact factor: 7.329

Review 10.  Fertility preservation in women.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Nat Rev Endocrinol       Date:  2013-10-29       Impact factor: 43.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.